Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 136Recruiting 48Terminated 44Unknown 43Active not recruiting 21Withdrawn 13Not yet recruiting 10Suspended 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Locally Recurrent Skin Squamous Cell Carcinoma 1

Interventions

aldesleukin 2Oxaliplatin 2Interleukin-2 2Cetuximab 2Bevacizumab 2vactosertib 1titanium silicide 1regorafenib 1fludarabine phosphate 1encorafenib 1apatinib 1Specimen Handling 1S 1 (combination) 1Riluzole 1Radiotherapy 1Radiosurgery 1Nivolumab 1Maintenance 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Interviews as Topic 1IL32 protein, human 1Hepatectomy 1Focus Groups 1Fluorouracil 1Flavonoids 1Cyclophosphamide 1Colonoscopy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Colorectal Neoplasms × Cetuximab × Clear all
NCT06102902 2026-05-13

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05200442 2026-05-08

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

University of Chicago

Phase 1/2 Suspended
53 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡